FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/087304 [Registered on: 21/05/2025] Trial Registered Prospectively
Last Modified On: 20/05/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To know the efficacy between Vasaghruta and Kulattadi Kashaya in Asthma 
Scientific Title of Study   A Controlled Double Arm Open Labelled Clinical Trial to Evaluate the Efficacy of Vrusha Ghruta and Kulatthadi Kashaya in the Management of Tamaka Shwasa vis a vis Bronchial Asthma 
Trial Acronym  NILL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR NAYANA D R 
Designation  PG SCHOLOR 
Affiliation  Government Ayurveda Medical College and Hospital, Mysuru  
Address  Post Graduate Department of Kayachiktsa Government Ayurveda Medical College and Hospital, Mysuru Visvesvaraya Cir, Devaraja Mohalla, Mandi Mohalla, Mysuru, Karnataka 570001
Post Graduate Department of Kayachikitsa Government Ayurveda Medical College and Hospital Mysuru Vishweshwaraiah circle Devraja Mohalla Mysuru Karnataka 570001 India Mysore KARNATAKA 570001 India
Mysore
KARNATAKA
570001
India 
Phone  9113853433  
Fax    
Email  nayanadrbaby@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR Sanjay Kumar M D 
Designation  Professor  
Affiliation  Government Ayurveda Medical College and Hospital, Mysuru  
Address  Post Graduate Department of Kayachikitsa Government Ayurveda Medical College and Hospital, Mysuru Visvesvaraya Cir, Devaraja Mohalla, Mandi Mohalla, Mysuru, Karnataka 570001
Post Graduate Department of Kayachikitsa Government Ayurveda Medical College and Hospital Mysuru Vishweshwaraiah circle Devraja Mohalla Mysuru Karnataka 570001 India Mysore KARNATAKA 570001 India
Mysore
KARNATAKA
570001
India 
Phone  9986083244  
Fax    
Email  drsanjaygowda@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR Nayana D R 
Designation  PG Scholar 
Affiliation  Government Ayurveda Medical College and Hospital, Mysuru 
Address  Post Graduate Department of Kayachikitsa Government Ayurveda Medical College and Hospital, Mysuru Visvesvaraya Cir, Devaraja Mohalla, Mandi Mohalla, Mysuru, Karnataka 570001
Post Graduate Department of Kayachikitsa, Government Ayurveda Medical College and Hospital, Mysuru Visvesvaraya Cir, Devaraja Mohalla, Mandi Mohalla, Mysuru, Karnataka 570001
Mysore
KARNATAKA
570001
India 
Phone  9113853433  
Fax    
Email  nayanadrbaby@gmail.com  
 
Source of Monetary or Material Support  
Government Ayurveda Medical College and Hospital, Mysuru Visvesvaraya Cir, Devaraja Mohalla, Mandi Mohalla, Mysuru, Karnataka 570001 
 
Primary Sponsor  
Name  DR NAYANA D R 
Address  Government Ayurveda Medical College and Hospital, Mysuru Visvesvaraya Cir, Devaraja Mohalla, Mandi Mohalla, Mysuru, Karnataka 570001 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR Nayana D R  Government Ayurveda Medical College,Mysuru  Department of Kayachikitsa,opd no 10, Government Ayurveda Medical College, 8M72+VJ5, Visvesvaraya Cir, Devaraja Mohalla, Mandi Mohalla, Mysuru, Karnataka 570001
Mysore
KARNATAKA 
9113853433

nayanadrbaby@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
The institutional Ethics committee of GAMC, Mysuru  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J452||Mild intermittent asthma. Ayurveda Condition: TAMAKASVASAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Vrusha Ghruta for Group A, Reference: Sahasra yoga , Route: Oral, Dosage Form: Ghrita, Dose: 12(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 23 Days, anupAna/sahapAna: No, Additional Information: For group A for the first 7 days (1st day to 7th) • Sthanika abhyanga with lavana yukta Vishagarbha taila followed by Nadisweda, Nithya mrudu virechana with Gandarva hasthadi eranda taila 10 ml before food in empty stomach at 7pm with ushnodaka for first consecutive 7days (1st –7thday)
2Intervention ArmDrugClassical(1) Medicine Name: Kulattadi Kashaya for Group B, Reference: Chakradatta, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 15(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 23 Days, anupAna/sahapAna: No, Additional Information: -For group B for the first 7 days (1st day to 7th) • Sthanika abhyanga with lavana yukta Vishagarbha taila followed by Nadisweda, Nithya mrudu virechana with Gandarva hasthadi eranda taila 10 ml before food in empty stomach at 7pm with ushnodaka for first consecutive 7days (1st –7thday) As a prakskepaka dravya Pushkara moola churna 1.5gm is added in Kulattadi Kashaya
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1)Subjects fulfilling the diagnostic criteria of Tamaka Swasa.
2)Subjects having peak expiratory flow rate of greter than 50percent of predicted value of Peak Expiratory Flow Rate chart.
3)Subjects within the age group of 18 to 60 years.
4) Both fresh and treated cases 
 
ExclusionCriteria 
Details  1) Acute condition of Bronchial Asthma, Status Asthmaticus.
2) Subjects suffering from associated diseases like Tuberculosis, pneumonia,Cardiac asthma,Uncontrolled Diabetes mellitus FBS 180ml by dl,Uncontrolled Hypertension BP 160by100mmhg
3) Subjects having peak expiratory flow rate of lessthan 50percent of predicted value of Peak Expiratory Flow
Rate chart.
4)Subjects who are on corticosteroids.
5)Pregnant and lactating women. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
1)Asthma control questionaire value less than 1.5
 
0th day, 8th day, 31st day.
 
 
Secondary Outcome  
Outcome  TimePoints 
Symptomatically relief to the patient  0th day 8th day and 31st day 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary     Tamaka Shwasa is one among the five varieties of Shwasa roga manifested due to vitiation of kapha-vata dosha and rasa dhatu in pranavaha srotas, originating from pittastana. Shwasa krichrata, kasa, ghurghuraka and prana peedana are the pradhana lakshana Asthma is defined as a chronic inflammatory disorder of the airways which is associated with airway hyper responsiveness. It leads to recurrent episodes of wheezing, breathlessness, chest tightness and coughing particularly at night and in early morning . According to WHO, Globally, Asthma has affected an estimated 262 million people in 2019. The overall burden of asthma in India is estimated to be more than 15 million . Asthma, owing to its chronic nature, has a significant impact on quality of life in patients due to the decreased capacity of physical exertion, constant dependence on medications, decreased quality of sleep, low performance at work and constant fear of trigger factors. The current management of Bronchial Asthma in modern medicine is only providing short term symptomatic relief but does not provide any long-term relief to the patient. On the other hand, prolonged use of these drugs are not safe, as it has many adverse effect with systemic manifestation and as the chronicity increases drug dose dependency increases. Ayurveda is the best way to effectively & safely manage the condition without inducing any drug dependency. Various shodhana procedures and internal medications are advised. They detoxify the body, provides nutrition to tissues, increases the elasticity of lung tissue and develops natural immunity. Thus, decreasing episodic recurrence of the disease and providing long term relief to the patient . Kapha is the sthanika dosha involved in Tamaka shwasa and it will cause obstruction to vata leading to a Pratiloma gati  of vata.kaphavruta vata samprapti is observed in tamaka shwasa and it is important to remove the obstruction and clearing the vata marga. The management protocol for kaphavruta vata includes usage of kaphahara dravya and achieving vatanulomana, lavana taila abhyanga and nadi sweda told as primary treatment in shwasa. Hence Sthanika abhyanga with samudra lavana yukta Vishagarbha taila followed by nadi sweda and Nithya mrudu virechana with Gandharva hastadi eranda taila are selected in the study. Vasa is present in Vrusha ghruta which is kasa shwasahara,hence Vrusha ghruta has been selected for the study. kulatta is also having the property of kasa shwasahara. Hence the present study is designed to compare the efficacy and internally vrusha ghrutha and kulattadi Kashaya in patients of Tamaka Shwasa keeping Nithyavirechana, Lavanataila abhyanga followed by Nadisweda as control in both the groups. 
Close